Pro Dex (PDEX) Cash from Discontinued Operations (2020 - 2021)

Pro Dex's (PDEX) quarterly Cash from Discontinued Operations came in at 307000.0 in Q3 2021, up 8.48% year-on-year from 283000.0 in Q3 2020, and up 8.48% quarter-over-quarter from 283000.0 in Q3 2020.

Pro Dex (PDEX) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

Pro Dex has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 307000.0 for Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Pro Dex 200.16 Mn 192.54 Mn 6.13 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 307,000.00
Sep 30, 2021 307,000.00
Sep 30, 2020 283,000.00
Sep 30, 2020 283,000.00